SARS-CoV-2 Spike receptor binding domain, RBD (352-365) – Lys(Biotin-LC) – 0.1 mg

Overview

The SARS-CoV-2 Spike receptor binding domain, RBD (352-365) – Lys(Biotin-LC) is a highly relevant peptide sequence crucial for research in virology and immunology. This peptide corresponds to residues 352-365 of the receptor binding domain, derived from the spike protein of the SARS-CoV-2 virus, as referenced in the RefSeq database (YP_009724390.1). The incorporation of Biotin-LC at the C-terminus enhances its utility in various applications, including diagnostic assays and antibody interactions.

Key Features

• Specific peptide sequence representing RBD residues 352-365
• C-terminal Biotin-LC labeling for easy detection
• Ideal for research on SARS-CoV-2 and related coronaviruses
• Supports development of assay kits and diagnostic tools
• Available in a 0.1 mg quantity

Specifications

FAQ

What is the significance of the SARS-CoV-2 Spike RBD?

The Spike receptor binding domain plays a critical role in the virus’s ability to attach to host cells, making it a focal point for vaccine and therapeutic research.

How can I use this peptide in my experiments?

This peptide can be utilized in various assays, particularly for detecting antibodies against SARS-CoV-2. Its Biotin labeling allows for easy conjugation with streptavidin-based detection methods.

Where can I find more peptide products?

You can explore our full range of peptides to find additional options for your research needs.

By choosing the SARS-CoV-2 Spike receptor binding domain, you are investing in a critical tool for advancing your research. Our peptide is designed for optimal performance in a variety of applications, ensuring that your research remains at the forefront of scientific discovery. Don’t miss out, add this essential peptide to your lab’s inventory today!

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled